TheManagement Board of Medinice S.A. with its registered office in Warsaw("Company") informs that the Management Board of the Warsaw StockExchange S.A. adopted Resolution No. 479/2026 regarding the admissionand introduction to stock exchange trading on the WSE Main Market of theCompany's ordinary bearer shares of series N, L2 and L3. The followingwere admitted to stock exchange trading on the main market: 1,304,348ordinary bearer shares of series N of the Company with a nominal valueof PLN 0.10 each, 110,000 ordinary bearer shares of series L2 of theCompany with a nominal value of PLN 0.10 each, and 176,643 ordinarybearer shares of series L3 of the Company with a nominal value of PLN0.10 each.

TheManagement Board of the Warsaw Stock Exchange S.A. decided to introduce,as of 7 April 2026, the above-mentioned series N, L2 and L3 shares ofthe Company to stock exchange trading on the main market, provided thatthe National Depository for Securities S.A. performs, on 7 April 2026,their assimilation with the Company's listed shares designated with thecode "PLMDNCE00016".